Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 4478-4484

  Uddin, Jasim ^a   Gonzalez, Armando E ^b   Gilman, Robert H ^b,d   Thomas, Lynette H ^a   Rodriguez, Silvia ^b   Evans, Carlton A W ^a,b,d   Remick, Daniel G ^e   Garcia, Hector H ^b,c   Friedland, Jon S ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OXFENDAZOLE; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; ANTIPARASITIC AGENT; CHEMOKINE; PARASITE ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYST FLUID; CYTOKINE RELEASE; DRUG EFFECT; EXPERIMENTAL PIG; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCYTE; NEUROCYSTICERCOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCOLEX; ANIMAL; CELL CULTURE; CYST; IMMUNOLOGY; INFLAMMATION; METABOLISM; SWINE;

ANIMALS; ANTIGENS, HELMINTH; ANTIPARASITIC AGENTS; CELLS, CULTURED; CHEMOKINES; CYSTS; HUMANS; INFLAMMATION; INTERLEUKIN-8; MONOCYTES; NEUROCYSTICERCOSIS; SWINE;

EID: 77958136191     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904158     Document Type: Article

References (54)

1. Hotez, P. J., M. E. Bottazzi, C. Franco-Paredes, S. K. Ault, and M. R. Periago. 2008. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2: e300.
2. Schantz, P. M., A. C. Moore, J. L. Muñoz, B. J. Hartman, J. A. Schaefer, A. M. Aron, D. Persaud, E. Sarti, M. Wilson, and A. Flisser. 1992. Neurocysticercosis in an Orthodox Jewish community in New York City. N. Engl. J. Med. 327:692-695.
3. Ong, S., D. A. Talan, G. J. Moran, W. Mower, M. Newdow, V. C. Tsang, R. W. Pinner; EMERGEncy ID NET Study Group. 2002. Neurocysticercosis in radiographically imaged seizure patients in U. S. emergency departments. Emerg. Infect. Dis. 8:608-613.
4. Garcia, H. H., O. H. Del Brutto; Cysticercosis Working Group in Peru. 2005. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 4:653-661.
5. Garcia, H. H., A. E. Gonzalez, R. H. Gilman; Cysticerosis Working Group in Peru. 2003. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr. Opin. Infect. Dis. 16:411-419.
6. Nash, T. E., G. Singh, A. C. White, V. Rajshekhar, J. A. Loeb, J. V. Proaño, O. M. Takayanagui, A. E. Gonzalez, J. A. Butman, C. De Giorgio, et al. 2006. Treatment of neurocysticercosis: current status and future research needs. Neurology 67:1120-1127.
7. Wang, I. C., P. C. Fan, S. C. Lu, C. K. Fan, and K. E. Su. 2008. Suppression of host Th1-type granulomatous inflammation by Taenia solium metacestodes is related to down-regulation of osteopontin gene expression. Int. J. Parasitol. 38:239-248.
8. García, H. H., C. A. Evans, T. E. Nash, O. M. Takayanagui, A. C. White, Jr., D. Botero, V. Rajshekhar, V. C. Tsang, P. M. Schantz, J. C. Allan, et al. 2002. Current consensus guidelines for treatment of neurocysticercosis. Clin. Microbiol. Rev. 15:747-756.
9. Robinson, P., R. L. Atmar, D. E. Lewis, and A. C. White, Jr. 1997. Granuloma cytokines in murine cysticercosis. Infect. Immun. 65:2925-2931.
10. Toenjes, S. A., and R. E. Kuhn. 2003. The initial immune response during experimental cysticercosis is of the mixed Th1/Th2 type. Parasitol. Res. 89:407-413.
11. Villa, O. F., and R. E. Kuhn. 1996. Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena. Parasitology 112:561-570.
12. Patil, S., P. Robinson, J. K. Actor, S. Baig, and A. C. White, Jr. 2006. Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures. J. Parasitol. 92:738-741.
13. Roach, D. R., A. G. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168:4620-4627.
14. Joseph, A. L., and D. L. Boros. 1993. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J. Immunol. 151:5461-5471.
15. Cardona, A. E., P. A. Gonzalez, and J. M. Teale. 2003. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infect. Immun. 71:2634-2642.
16. Uddin, J., H. H. Garcia, R. H. Gilman, A. E. Gonzalez, and J. S. Friedland. 2005. Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis. J. Immunol. 175:3273-3281.
17. Uddin, J., A. E. Gonzalez, R. H. Gilman, H. H. Garcia, M. Verastegui, L. J. Moore, C. A. Evans, R. C. Read, and J. S. Friedland. 2006. Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway. Microbes Infect. 8:1732-1740.
18. Bacon, K. B., and J. K. Harrison. 2000. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J. Neuroimmunol. 104:92-97.
19. Glabinski, A. R., and R. M. Ransohoff. 1999. Chemokines and chemokine receptors in CNS pathology. J. Neurovirol. 5:3-12.
20. Mondragón-de-la-Peña, C., S. Ramos-Solís, O. Barbosa-Cisneros, C. Rodríguez-Padilla, P. Tavizón-García, and R. Herrera-Esparza. 2002. Echinococcus granulosus down regulates the hepatic expression of inflammatory cytokines IL-6 and TNF alpha in BALB/c mice. Parasite 9:351-356.
21. King, C. L., A. Medhat, I. Malhotra, M. Nafeh, A. Helmy, J. Khaudary, S. Ibrahim, M. El-Sherbiny, S. Zaky, R. J. Stupi, et al. 1996. Cytokine control of parasitespecific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J. Immunol. 156:4715-4721.
22. Rodrigues, V., Jr., F. A. de-Mello, E. P. Magalhães, S. B. Ribeiro, and J. O. Marquez. 2000. Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis. Braz. J. Med. Biol. Res. 33:1059-1063.
23. Gogos, C. A., E. Drosou, H. P. Bassaris, and A. Skoutelis. 2000. Pro-versus antiinflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis. 181:176-180.
24. van Dissel, J. T., P. van Langevelde, R. G. Westendorp, K. Kwappenberg, and M. Frölich. 1998. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351:950-953.
25. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
26. Yin, E. T., C. Galanos, S. Kinsky, R. A. Bradshaw, S. Wessler, O. Lüderitz, and M. E. Sarmiento. 1972. Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim. Biophys. Acta 261:284-289.
27. Tsang, V. C., J. A. Brand, and A. E. Boyer. 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J. Infect. Dis. 159:50-59.
28. Eskandari, M. K., D. T. Nguyen, S. L. Kunkel, and D. G. Remick. 1990. WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol. Invest. 19:69-79.
29. De Forge, L. E., and D. G. Remick. 1991. Sandwich ELISA for detection of picogram quantities of interleukin-8. Immunol. Invest. 20:89-97.
30. Ameixa, C., and J. S. Friedland. 2001. Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and-10 but not by interleukin-13. Infect. Immun. 69:2470-2476.
31. Restrepo, B. I., P. Llaguno, M. A. Sandoval, J. A. Enciso, and J. M. Teale. 1998. Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2. J. Neuroimmunol. 89:64-72.
32. Cardona, A. E., B. I. Restrepo, J. M. Jaramillo, and J. M. Teale. 1999. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J. Immunol. 162:995-1002.
33. Gonzales, A. E., H. H. Garcia, R. H. Gilman, C. M. Gavidia, V. C. Tsang, T. Bernal, N. Falcon, M. Romero, and M. T. Lopez-Urbina. 1996. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am. J. Trop. Med. Hyg. 54:391-394.
34. Bueno, E. C., A. J. Vaz, L. R. Machado, J. A. Livramento, S. L. Avila, and A. W. Ferreira. 2001. Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis. Clin. Exp. Immunol. 126:304-310.
35. Prasad, A., K. N. Prasad, R. K. Gupta, and S. Pradhan. 2009. Increased expression of ICAM-1 among symptomatic neurocysticercosis. J. Neuroimmunol. 206:118-120.
36. Thussu, A., S. Sehgal, M. Sharma, V. Lal, I. M. Sawhney, and S. Prabhakar. 1997. Comparison of cellular responses in single-and multiple-lesion neurocysticercosis. Ann. Trop. Med. Parasitol. 91:627-632.
37. Gu, L., S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407-411.
38. Rodriguez-Sosa, M., J. R. David, R. Bojalil, A. R. Satoskar, and L. I. Terrazas. 2002. Cutting edge: susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. J. Immunol. 168:3135-3139.
39. Mosser, D. M., and X. Zhang. 2008. Interleukin-10: new perspectives on an old cytokine. Immunol. Rev. 226:205-218.
40. Dematteis, S., F. Pirotto, J. Marqués, A. Nieto, A. Orn, and A. Baz. 2001. Modulation of the cellular immune response by a carbohydrate rich fraction from Echinococcus granulosus protoscoleces in infected or immunized Balb/c mice. Parasite Immunol. 23:1-9.
41. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
42. Hernandez-Mendoza, L., J. L. Molinari, E. Garrido, I. Cortes, S. Solano, E. Miranda, and P. Tato. 2005. The implantation of Taenia solium metacestodes in mice induces down-modulation of T-cell proliferation and cytokine production. Parasitol. Res. 95:256-265.
43. Tato, P., A. C. White, Jr., K. Willms, D. Rodríguez, S. Solano, J. Sepúlveda, and J. L. Molinari. 1996. Immunosuppression and inhibition of inflammation in mice induced by a small Taenia solium RNA-peptide to implanted T. solium metacestodes. Parasitol. Res. 82:590-597.
44. Arechavaleta, F., J. L. Molinari, and P. Tato. 1998. A Taenia solium metacestode factor nonspecifically inhibits cytokine production. Parasitol. Res. 84:117-122.
45. Takayanagui, O. M., and N. S. Odashima. 2006. Clinical aspects of neurocysticercosis. Parasitol. Int. 55 (Suppl.): S111-S115.
46. Burgmann, H., U. Hollenstein, C. Wenisch, F. Thalhammer, S. Looareesuwan, and W. Graninger. 1995. Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 76:32-36.
47. Zwingenberger, K., E. Irschick, J. G. Vergetti Siqueira, A. R. Correia Dacal, and H. Feldmeier. 1990. Tumour necrosis factor in hepatosplenic schistosomiasis. Scand. J. Immunol. 31:205-211.
48. Kern, P., C. J. Hemmer, J. Van Damme, H. J. Gruss, and M. Dietrich. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87:139-143.
49. Scuderi, P., K. E. Sterling, K. S. Lam, P. R. Finley, K. J. Ryan, C. G. Ray, E. Petersen, D. J. Slymen, and S. E. Salmon. 1986. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 2:1364-1365.
50. White, A. C., Jr., J. L. Molinari, A. V. Pillai, and A. A. Rege. 1992. Detection and preliminary characterization of Taenia solium metacestode proteases. J. Parasitol. 78:281-287.
51. Chavarria, A., A. Fleury, R. J. Bobes, J. Morales, G. Fragoso, and E. Sciutto. 2006. A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis. Microbes Infect. 8:1082-1089.
52. Medina-Escutia, E., Z. Morales-López, J. V. Proaño, J. Vazquez, V. Bermúdez, V. O. Navarrete, V. Madrid-Marina, J. P. Laclette, and D. Correa. 2001. Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis: lack of immune suppression. J. Parasitol. 87:587-590.
53. Restrepo, B. I., M. I. Aguilar, P. C. Melby, and J. M. Teale. 2001. Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Am. J. Trop. Med. Hyg. 65:366-370.
54. Evans, C. A., H. H. Garcia, A. Hartnell, R. H. Gilman, P. J. Jose, M. Martinez, D. G. Remick, T. J. Williams, and J. S. Friedland. 1998. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect. Immun. 66:4522-4525.